Stock Recommendations for the Week of September 15, 2026
Motilal Oswal Wealth Management Research Desk has released its stock recommendations for the trading week beginning September 18, 2026. The firm has identified Emcure Pharmaceuticals and Cholamandalam Investment & Finance Company Ltd as the top stocks to consider during this holiday-shortened week.
Emcure Pharmaceuticals is experiencing robust growth across its domestic and international markets, particularly in Europe, Canada, and other regions. In the first quarter of FY27, the company reported a revenue increase of 22.8% year-over-year, reaching INR 25.8 billion. Additionally, EBITDA rose by 25.8% to INR 5.1 billion, and the adjusted profit after tax increased by 34% to INR 2.9 billion. Despite a contraction in gross margin, management anticipates continued revenue growth supported by new product launches and improved domestic execution.
For Your Trading Desk
Sponsor Spike Success.
Cholamandalam Investment & Finance Company Ltd is transitioning from a vehicle-finance specialist to a more diversified lending platform. This shift is expected to drive the next phase of growth, with mortgage lending emerging as a key growth area alongside its traditional vehicle-finance business. The company is also expanding into higher-yielding sectors such as gold loans and consumer finance. Despite rising funding costs, the company maintains resilient margins and is projected to see improvements in return on assets and equity over the coming years.
Investment Outlook for Emcure and Cholamandalam Stocks
Both companies are positioned for significant growth, with Emcure expected to achieve a revenue compound annual growth rate of 15% and Cholamandalam targeting a similar trajectory for its assets under management and profit after tax. Investors are advised to consider these stocks as part of their portfolio for the upcoming trading week.




